患者和医生对低风险前列腺癌治疗方法的看法:一种定性研究
Alice Guan1, Eduardo J Santiago-Rodríguez1, Benjamin I Chung2
1Dept of Epidemiology & Biostatistics, University of California, San Francisco (UCSF), San Francisco, United States.
BMC cancer
|December 5, 2023
概括
患者和医生对低风险前列腺癌治疗决策的看法在很大程度上一致. 开发清晰的沟通工具和教育材料可以支持积极监测与最终治疗的共享决策.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 患者与医生的沟通 患者与医生的沟通
背景情况:
- 低风险前列腺癌 (PCa) 患者在最终治疗和积极监测之间面临着关键的选择.
- 患者和医生如何评估决策因素的差异可能会使这种选择变得复杂.
- 一项定性研究探讨了患者和医生对影响低风险PCa治疗决定的因素的看法.
研究的目的:
- 了解患者和医生对影响低风险前列腺癌治疗决策的因素的看法.
- 确定患者和医生如何权衡临床和人际关系因素的潜在差异.
主要方法:
- 进行了半结构化采访,对43名被诊断患有低风险PCa的种族和种族不同患者进行了半结构化采访.
- 采访了大旧金山湾区各个实践场所的15名医生.
- 通过基于人口的癌症登记册来确定患者.
主要成果:
- 患者和医生都确定了影响决策的关键个人 (临床) 和人际 (沟通) 因素.
- 医生的看法通常反映了患者的看法,这表明了显著的共识.
- 基于年龄的偏好出现了差异,年龄较大的患者倾向于更少的侵入性选择;年轻的患者表现出不同的意见.
结论:
- 在低风险的PCa治疗决策中,患者和医生对临床和沟通因素的看法之间的差距很小.
- 观察到的共识强调需要有效的临床沟通策略和可访问的患者教育材料.
- 制定沟通路线图和高质量的教育资源可以加强共享决策.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Nursing Ethical Principles II
984
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
984
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:20Disorders of the Male Reproductive System
424
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
424
01:21Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174